We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Studies Reveal Pathway Linking Brain and CV Events

By MedImaging International staff writers
Posted on 01 Feb 2017
Print article
Image: An example of an FDG-PET imaging scan of the human brain (Photo courtesy of PubMed).
Image: An example of an FDG-PET imaging scan of the human brain (Photo courtesy of PubMed).
Researchers have for the first time found a pathway linking brain activity in the amygdala, elevated immune system activity and inflammation, and cardiovascular events in human beings.

In the first study the researchers analyzed imaging and medical records of nearly 300 patients who had undergone Positron Emission Tomography/Computed Tomography (PET/CT) brain imaging. The second included 13 individuals who had a history of Post-Traumatic Stress Disorder (PTSD) and underwent fluorodeoxyglucose-PET (FDG-PET) imaging intended to measure amygdala activity, and the inflammation of arteries.

The research was led by the Massachusetts General Hospital and Icahn School of Medicine at Mount Sinai Hospital, and was published in the January 11, 2017, issue of the journal The Lancet. The complementary studies were conducted at MGH, and at ISMMS.

The results showed that prior levels of amygdala activity strongly predicted the risk of a subsequent cardiovascular event. Such activity was also associated with the timing of the event, to elevated activity of the blood-cell-forming tissue, and to increased arterial inflammation.

Lead author of the paper, Ahmed Tawakol, MD at MGH, said, "While the link between stress and heart disease has long been established, the mechanism mediating that risk has not been clearly understood. These findings suggest several potential opportunities to reduce cardiovascular risk attributable to stress. It would be reasonable to advise individuals with increased risk of cardiovascular disease to consider employing stress-reduction approaches if they feel subjected to a high degree of psychosocial stress. In addition, increased stress associates with other diseases, such as cancer and inflammatory conditions, including rheumatoid arthritis and psoriasis. So it will be important to evaluate whether calming this stress mechanism produces benefits in those diseases as well."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Portable X-Ray Unit
AJEX240H
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
X-Ray Detector
FDR-D-EVO III

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.